Braster S.A. Stock

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:52 2025-11-27 EST			5-day change	1st Jan Change
0.5800 ^PLN	-.--%		-.--%	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Employees

Sector

Biotechnology & Medical Research

More about the company

Income Statement and Estimates

More financial data

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	17.04M 4.5M 3.94M 3.63M 3.35M 6.37M 429M 6.47M 43.4M 212M 16.9M 16.54M 727M	P/E 2022	-5.18x	P/E 2023	-3.55x
Enterprise Value	28.34M 7.49M 6.55M 6.04M 5.58M 10.59M 714M 10.76M 72.18M 352M 28.11M 27.5M 1.21B	EV / Sales 2022	15.4x	EV / Sales 2023	88.9x
Free-Float	80.79%	Yield 2022 *	-	Yield 2023	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-03	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-11-21	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-09-27	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-09-30	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-09-22	An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	CI

5 years	0.53		1.52
10 years	0.19		30

Director	Title	Age	Since
Katarzyna Kilijanczyk BRD	Director/Board Member	-	-
Elzbieta Kozik BRD	Director/Board Member	-	-
Zygfryd Kosidowski BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRASTER S.A.	-.--%	-.--%	-	-	4.61M
VERACYTE, INC.	-3.93%	-0.19%	+110.38%	+108.07%	4.55B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-3.39%	-0.61%	+78.17%	+203.46%	3.37B
BGI GENOMICS CO., LTD.	+4.20%	-1.15%	-27.01%	-39.95%	2.05B
IOVANCE BIOTHERAPEUTICS, INC.	-3.20%	-1.86%	+126.20%	-46.66%	1.89B
CAREDX, INC.	-2.06%	-2.33%	+41.63%	+175.73%	1.47B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+2.01%	+0.83%	+123.08%	-50.04%	898M
SEEGENE, INC.	+6.42%	-1.19%	-10.08%	+43.92%	880M
CURIOX BIOSYSTEMS CO., LTD	+7.05%	+1.07%	-2.63%	-	487M
HANGZHOU ALLTEST BIOTECH CO., LTD.	+1.63%	-3.18%	-36.79%	-18.41%	483M
Average	+0.87%	-0.72%	+44.77%	+47.01%	1.61B
Weighted average by Cap.	-1.12%	-0.66%	+67.94%	+80.23%

Braster S.A. Stock

Stocks

BRA

PLBRSTR00014

Biotechnology & Medical Research

Valuation: Braster S.A.

Chart: Braster S.A.

Latest news : Braster S.A.

Course Extremes

Managers and Directors: Braster S.A.

Bio Diagnostics & Testing

Financials

Company Profile

Income Statement and Estimates

	2022	2023
Net sales	2.24M 592K 518K 477K 441K 837K 56.43M 851K 5.7M 27.8M 2.22M 2.17M 95.58M	319K 84.27K 73.71K 67.99K 62.79K 119K 8.04M 121K 812K 3.96M 316K 310K 13.61M
Net income	-3.87M -1.02M -895K -825K -762K -1.45M -97.55M -1.47M -9.86M -48.06M -3.84M -3.76M -165M	-4.75M -1.25M -1.1M -1.01M -935K -1.77M -120M -1.8M -12.09M -58.93M -4.71M -4.61M -203M
Net Debt	12.42M 3.28M 2.87M 2.65M 2.44M 4.64M 313M 4.72M 31.62M 154M 12.31M 12.05M 530M	11.3M 2.99M 2.61M 2.41M 2.22M 4.22M 285M 4.29M 28.78M 140M 11.21M 10.97M 482M